N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide

C140H150F6N30O21 — CID 161002392

IUPACN-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide
SMILESC=CC(=O)N1CCC[C@@H](Oc2nc(Nc3cccc(OCCN4CCCC4=O)c3)ncc2F)C1.C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3cccc(OCCN4CCOCC4)c3)ncc2F)C1.C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CN4CCN(C)CC4)cc3)ncc2F)c1.C=CC(=O)Nc1cccc(Oc2nc(Nc3cc(OC)c(OC)c(OC)c3)ncc2F)c1.C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(CN4CCOCC4)cc3)ncc2F)c1.C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)c(OC)c3)ncc2F)c1
InChIInChI=1S/C25H28FN7O.C24H28FN5O4.C24H30FN5O4.C24H24FN5O3.C22H21FN4O5.C21H19FN4O4/c1-3-23(34)28-20-5-4-6-21(15-20)29-24-22(26)16-27-25(31-24)30-19-9-7-18(8-10-19)17-33-13-11-32(2)12-14-33;1-2-21(31)30-11-4-8-19(16-30)34-23-20(25)15-26-24(28-23)27-17-6-3-7-18(14-17)33-13-12-29-10-5-9-22(29)32;1-2-22(31)30-8-4-7-20(17-30)34-23-21(25)16-26-24(28-23)27-18-5-3-6-19(15-18)33-14-11-29-9-12-32-13-10-29;1-2-22(31)27-19-4-3-5-20(14-19)33-23-21(25)15-26-24(29-23)28-18-8-6-17(7-9-18)16-30-10-12-32-13-11-30;1-5-19(28)25-13-7-6-8-15(9-13)32-21-16(23)12-24-22(27-21)26-14-10-17(29-2)20(31-4)18(11-14)30-3;1-4-19(27)24-13-6-5-7-15(10-13)30-20-16(22)12-23-21(26-20)25-14-8-9-17(28-2)18(11-14)29-3/h3-10,15-16H,1,11-14,17H2,2H3,(H,28,34)(H2,27,29,30,31);2-3,6-7,14-15,19H,1,4-5,8-13,16H2,(H,26,27,28);2-3,5-6,15-16,20H,1,4,7-14,17H2,(H,26,27,28);2-9,14-15H,1,10-13,16H2,(H,27,31)(H,26,28,29);5-12H,1H2,2-4H3,(H,25,28)(H,24,26,27);4-12H,1H2,2-3H3,(H,24,27)(H,23,25,26)/t;19-;20-;;;/m.11.../s1
InChIKeyTWBBFFZGNOHSMJ-HWJSYEQLSA-N
MW2702.92 g/mol
LogP22.22
Rot. Bonds51

About N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide

N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide (PubChem CID 161002392) has the molecular formula C140H150F6N30O21 and a molecular weight of 2702.92 g/mol. Its IUPAC name is N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide.

Molecular Properties

Compound NameN-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide
PubChem CID161002392
Molecular FormulaC140H150F6N30O21
Molecular Weight2702.92 g/mol
Exact Mass2701.15
IUPAC NameN-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide
SMILESC=CC(=O)N1CCC[C@@H](Oc2nc(Nc3cccc(OCCN4CCCC4=O)c3)ncc2F)C1.C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3cccc(OCCN4CCOCC4)c3)ncc2F)C1.C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CN4CCN(C)CC4)cc3)ncc2F)c1.C=CC(=O)Nc1cccc(Oc2nc(Nc3cc(OC)c(OC)c(OC)c3)ncc2F)c1.C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(CN4CCOCC4)cc3)ncc2F)c1.C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)c(OC)c3)ncc2F)c1
InChIInChI=1S/C25H28FN7O.C24H28FN5O4.C24H30FN5O4.C24H24FN5O3.C22H21FN4O5.C21H19FN4O4/c1-3-23(34)28-20-5-4-6-21(15-20)29-24-22(26)16-27-25(31-24)30-19-9-7-18(8-10-19)17-33-13-11-32(2)12-14-33;1-2-21(31)30-11-4-8-19(16-30)34-23-20(25)15-26-24(28-23)27-17-6-3-7-18(14-17)33-13-12-29-10-5-9-22(29)32;1-2-22(31)30-8-4-7-20(17-30)34-23-21(25)16-26-24(28-23)27-18-5-3-6-19(15-18)33-14-11-29-9-12-32-13-10-29;1-2-22(31)27-19-4-3-5-20(14-19)33-23-21(25)15-26-24(29-23)28-18-8-6-17(7-9-18)16-30-10-12-32-13-11-30;1-5-19(28)25-13-7-6-8-15(9-13)32-21-16(23)12-24-22(27-21)26-14-10-17(29-2)20(31-4)18(11-14)30-3;1-4-19(27)24-13-6-5-7-15(10-13)30-20-16(22)12-23-21(26-20)25-14-8-9-17(28-2)18(11-14)29-3/h3-10,15-16H,1,11-14,17H2,2H3,(H,28,34)(H2,27,29,30,31);2-3,6-7,14-15,19H,1,4-5,8-13,16H2,(H,26,27,28);2-3,5-6,15-16,20H,1,4,7-14,17H2,(H,26,27,28);2-9,14-15H,1,10-13,16H2,(H,27,31)(H,26,28,29);5-12H,1H2,2-4H3,(H,25,28)(H,24,26,27);4-12H,1H2,2-3H3,(H,24,27)(H,23,25,26)/t;19-;20-;;;/m.11.../s1
InChIKeyTWBBFFZGNOHSMJ-HWJSYEQLSA-N
XLogP22.22
TPSA558.40 Ų
H-Bond Donors11
H-Bond Acceptors44
Rotatable Bonds51
Heavy Atoms197
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002702.92
LogP ≤ 522.22
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1044

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide?
The IUPAC name of N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide (CID 161002392) is N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide.
What is the SMILES notation for N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide?
The canonical SMILES for N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide is C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3cccc(OCCN4CCCC4=O)c3)ncc2F)C1.C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3cccc(OCCN4CCOCC4)c3)ncc2F)C1.C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CN4CCN(C)CC4)cc3)ncc2F)c1.C=CC(=O)Nc1cccc(Oc2nc(Nc3cc(OC)c(OC)c(OC)c3)ncc2F)c1.C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(CN4CCOCC4)cc3)ncc2F)c1.C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)c(OC)c3)ncc2F)c1.
What is the InChIKey of N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide?
The InChIKey is TWBBFFZGNOHSMJ-HWJSYEQLSA-N. The full InChI is InChI=1S/C25H28FN7O.C24H28FN5O4.C24H30FN5O4.C24H24FN5O3.C22H21FN4O5.C21H19FN4O4/c1-3-23(34)28-20-5-4-6-21(15-20)29-24-22(26)16-27-25(31-24)30-19-9-7-18(8-10-19)17-33-13-11-32(2)12-14-33;1-2-21(31)30-11-4-8-19(16-30)34-23-20(25)15-26-24(28-23)27-17-6-3-7-18(14-17)33-13-12-29-10-5-9-22(29)32;1-2-22(31)30-8-4-7-20(17-30)34-23-21(25)16-26-24(28-23)27-18-5-3-6-19(15-18)33-14-11-29-9-12-32-13-10-29;1-2-22(31)27-19-4-3-5-20(14-19)33-23-21(25)15-26-24(29-23)28-18-8-6-17(7-9-18)16-30-10-12-32-13-11-30;1-5-19(28)25-13-7-6-8-15(9-13)32-21-16(23)12-24-22(27-21)26-14-10-17(29-2)20(31-4)18(11-14)30-3;1-4-19(27)24-13-6-5-7-15(10-13)30-20-16(22)12-23-21(26-20)25-14-8-9-17(28-2)18(11-14)29-3/h3-10,15-16H,1,11-14,17H2,2H3,(H,28,34)(H2,27,29,30,31);2-3,6-7,14-15,19H,1,4-5,8-13,16H2,(H,26,27,28);2-3,5-6,15-16,20H,1,4,7-14,17H2,(H,26,27,28);2-9,14-15H,1,10-13,16H2,(H,27,31)(H,26,28,29);5-12H,1H2,2-4H3,(H,25,28)(H,24,26,27);4-12H,1H2,2-3H3,(H,24,27)(H,23,25,26)/t;19-;20-;;;/m.11.../s1.
What are the key properties of N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide?
N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide has a molecular weight of 2702.92 g/mol, XLogP of 22.22, 51 rotatable bonds, 11 hydrogen bond donors, and 44 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[2-(3,4-dimethoxyanilino)-5-fluoropyrimidin-4-yl]oxyphenyl]prop-2-enamide;N-[3-[[5-fluoro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide;1-[(3R)-3-[5-fluoro-2-[3-(2-morpholin-4-ylethoxy)anilino]pyrimidin-4-yl]oxypiperidin-1-yl]prop-2-en-1-one;N-[3-[5-fluoro-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;1-[2-[3-[[5-fluoro-4-[(3R)-1-prop-2-enoylpiperidin-3-yl]oxypyrimidin-2-yl]amino]phenoxy]ethyl]pyrrolidin-2-one;N-[3-[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxyphenyl]prop-2-enamide is sourced from PubChem (CID 161002392), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).